Further investigations indicated that DNMT3b knockdown inhibited the downstream targets of miR-34a, specifically hepatocyte nuclear factor 4γ (HNF4γ) and Notch1, leading to decreased migration and invasion of BC cell lines. Here, DNMT3B is linked to breast cancer.